Jeremy Lambert brings 20 years of experience in life sciences product development and commercialization from Caliper Life Sciences, PerkinElmer, and Quanterix
DURHAM, N.C.–(BUSINESS WIRE)–Codetta Bio, the life sciences company developing advanced multiomic biomarker measurement tools, announced today that Jeremy Lambert has joined the company as Vice President of Product Management. In this role, Lambert will lead the development and execution of Codetta’s commercial strategy as the company brings its breakthrough multiomic solution to market.
“Thanks to his broad knowledge of genomic and proteomic technology, Jeremy also has a clear understanding of the unique advantages of Codetta’s technology and its potential. I’m thrilled to welcome him to the team.”
“Jeremy has a proven track record as a strategic, customer and market-focused leader in life sciences technology product development,” said Anthony Lemmo, CEO of Codetta Bio. “Thanks to his broad knowledge of genomic and proteomic technology, Jeremy also has a clear understanding of the unique advantages of Codetta’s technology and its potential. I’m thrilled to welcome him to the team.”
Lambert joins Codetta with over 20 years of experience working in product development and commercialization of life science research technologies. Most recently, Lambert served as Vice President of Product Management at Quanterix, where during his tenure, the company grew from $12M to over $100M in revenue in protein biomarker measurement platforms. He has also held product marketing roles at several other life sciences technology companies including Caliper Life Sciences and PerkinElmer. Lambert has previously supported and led the identification, design, development, and marketing of various technology products in drug discovery and life sciences, with specific expertise in genomics and proteomics technology, instrumentation, reagents, and software.
“The data-driven insights that Codetta’s multiomic biomarker measurement tools can provide have the potential to uncover valuable information on diseases and help advance the research and development of new therapies,” said Lambert. “I’m looking forward to working alongside the rest of the Codetta team to develop a commercial strategy that will make our innovative solution widely accessible and ultimately improve outcomes for patients everywhere.”
To learn more about Codetta Bio, please visit http://www.codettabio.com.
About Codetta Bio
Codetta Bio is developing advanced multiomic biomarker measurement tools supporting data-driven approaches to understanding the unique genetic, environmental, lifestyle, and clinical factors that contribute to individual health and wellness. For more information, visit http://www.codettabio.com.
Contacts
Media Contact
Brandon Reid for Codetta Bio
bwr@anzupartners.com